Schizophreniform Disorder
📧 Sign up to get email alerts when something new happens for Schizophreniform Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Donepezil Double Blind Trial for ECT Memory Disfunction [Phase 4]
Phase 4 clinical trial update on a double-blind study of donepezil for memory dysfunction after electroconvulsive therapy in schizophrenia, …
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]
A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic
This clinical trial update tracks service use and outcomes for a clinic serving first-episode psychosis and related psychotic disorders. The…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Comparative Study of New Medications for Psychosis in Adolescents [NA]
This clinical trial update reports the completion of a comparative study evaluating new medications for psychosis in adolescents. The study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…